These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1362540)

  • 21. Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt.
    Abbadi S; Rashed HG; Morlock GP; Woodley CL; El Shanawy O; Cooksey RC
    J Clin Microbiol; 2001 Jun; 39(6):2330-4. PubMed ID: 11376084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
    Nolan CM; Williams DL; Cave MD; Eisenach KD; el-Hajj H; Hooton TM; Thompson RL; Goldberg SV
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1067-71. PubMed ID: 7663785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
    Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):328-32. PubMed ID: 15786899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
    Porvaznik I; Mokry J; Solovic I
    Adv Exp Med Biol; 2015; 835():15-22. PubMed ID: 25252893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis.
    Steiner P; Rao M; Mitchell M; Steiner M
    Am J Dis Child; 1985 Aug; 139(8):780-2. PubMed ID: 3927707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of fluoroquinolone-resistant tuberculosis in New York City.
    Sullivan EA; Kreiswirth BN; Palumbo L; Kapur V; Musser JM; Ebrahimzadeh A; Frieden TR
    Lancet; 1995 May; 345(8958):1148-50. PubMed ID: 7723548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping of rifampin-resistant Mycobacterium tuberculosis isolates from western Turkey.
    Cavusoglu C; Durmaz R; Bilgic A; Gunal S
    Ann Saudi Med; 2004; 24(2):102-5. PubMed ID: 15323270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy of multidrug-resistant tuberculosis: lessons from studies with mice.
    Klemens SP; DeStefano MS; Cynamon MH
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2344-7. PubMed ID: 8285617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan.
    Pfyffer GE; Strässle A; van Gorkum T; Portaels F; Rigouts L; Mathieu C; Mirzoyev F; Traore H; van Embden JD
    Emerg Infect Dis; 2001; 7(5):855-61. PubMed ID: 11747699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New antitubercular drugs].
    Krasucka-Kluźniak A
    Pneumonol Pol; 1990; 58(4-5):163-6. PubMed ID: 2168041
    [No Abstract]   [Full Text] [Related]  

  • 40. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Herbert D; Paramasivan CN; Venkatesan P; Kubendiran G; Prabhakar R; Mitchison DA
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2296-9. PubMed ID: 8891133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.